In connection with the implementation of the project entitled ‘Design and development of nanoparticle-RNA based drugs to be used in anti-cancer therapy with the construction of a nanoparticle platform for targeted delivery of therapeutic nucleic acids’ by Biotechna SA under agreement No. 2022/ABM/06/00005-00 for funding of the Commercial Project within the framework of the Competition for the development of targeted or personalised medicine based on therapeutic products based on nucleic acids and small-molecule compounds, the Contracting Authority is conducting a market survey concerning the costs of purchase and supply of laboratory reagents.
To submit an offer, please read the detailed description of the offer in the reguest for quotation 52/2025 and send us the completed offer form and the price-assortment form.